| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.1B | $15.4B | $15.8B | $4.0B | $4.1B | $4.4B | $3.7B | $3.6B |
| Cost of Revenue | $10.5B | $10.9B | $11.8B | $12.7B | $10.4B | $9.6B | $9.6B | $9.1B |
| Gross Profit | — | — | — | $0.8B | $1.2B | $1.6B | $1.2B | $1.2B |
| R&D Expense | $0.3B | $0.3B | $0.4B | $0.4B | $0.3B | $0.2B | $0.3B | $0.3B |
| SG&A Expense | $3.3B | $3.3B | $3.3B | $3.4B | $3.2B | $3.0B | $3.0B | $3.1B |
| Operating Income | — | — | — | — | — | $2.2B | $2.0B | $1.9B |
| Net Income | $0.4B | $0.3B | $-0.3B | $1.1B | $1.7B | $1.2B | $0.2B | $-0.1B |
| EPS (Basic) | $2.66 | $1.96 | $-2.07 | $-0.35 | $2.06 | $2.92 | $1.34 | $-0.72 |
| EPS (Diluted) | $2.65 | $1.95 | $-2.07 | $-0.34 | $1.99 | $2.88 | $1.32 | $-0.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.2B | $21.8B | $23.7B | $25.0B | $28.2B | $23.6B | $20.6B | $19.4B |
| Current Assets | $6.0B | $6.4B | $7.0B | $8.0B | $8.5B | $6.0B | $4.5B | $4.6B |
| Cash & Equivalents | $0.3B | $0.3B | $0.4B | $0.4B | $0.1B | $1.4B | $0.3B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $5.2B | $4.9B | $5.9B | $6.6B | $8.8B | $4.6B | $4.4B | $4.0B |
| Stockholders' Equity | $9.1B | $8.7B | $9.1B | $9.7B | $11.6B | $11.1B | $9.1B | $7.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $1.1B | $1.2B | $-1.5B | $0.7B | $2.0B | $1.5B | $1.3B |
| Investing Cash Flow | $-0.3B | $0.4B | $-0.3B | $3.6B | $-2.6B | $-1.6B | $-1.2B | $-1.0B |
| Capital Expenditures | $0.3B | $0.4B | $0.3B | $0.5B | $0.5B | $0.3B | $0.4B | $0.5B |
| Financing Cash Flow | $-0.8B | $-1.6B | $-0.8B | $-2.0B | $0.9B | $0.6B | $-0.3B | $-0.6B |